Mini-Symposium
Peripheral factors in the pathophysiology of irritable bowel syndrome

https://doi.org/10.1016/j.dld.2009.07.006Get rights and content

Abstract

The pathophysiology of IBS is complex and still incompletely known. Both central and peripheral factors are thought to contribute to the symptoms of IBS, including psychosocial factors, abnormal GI motility and secretion, and visceral hypersensitivity. In this review the involvement of peripheral factors in the pathophysiology in IBS is reviewed. Altered GI motility is commonly found in this patient group, even though a specific motor pattern has been hard to find. Colonic transit has been found to be of relevance for the bowel habit of the patient. Abnormal gas handling within the gut is also commonly seen, and seems to be one, but not the only factor responsive for bloating. There is also limited evidence supporting the presence of abnormal GI secretion in IBS, but its relevance for symptoms remains unclear. Visceral hypersensitivity is currently considered to be one of the most important pathophysiological factors in IBS. It can be modulated by several external and internal factors and recent studies support an association between colorectal sensitivity and the symptoms reported by the patients, especially pain.

Introduction

Irritable bowel syndrome (IBS) is characterized by pain and discomfort in the abdomen related to abnormal bowel habits [1]. It is one of the most common disorders encountered by gastroenterologists [2], [3] and also one of most common gastrointestinal disorders managed by general practitioners [4]. Unfortunately, truly effective therapeutic options for these patients are rare, and recent attempts to launch new treatment options have been disappointing [5], [6]. The prevalence of IBS varies depending on the diagnostic criteria used, but it appears to affect up to 20% of the population at any given time [7], [8], [9], [10]. Due to its high prevalence and, for many patients, chronic nature and incapacitating symptoms the cost of IBS to society is substantial, and IBS profoundly affects the daily lives of many patients leading to a low quality of life [11]. Therefore, both from an economical and humanitarian point of view, more effective treatment alternatives are needed for IBS.

Despite being very common, the pathophysiology of IBS is incompletely understood, which poses problems in the search for effective therapeutic alternatives. Altered psychosocial function, disturbed gastrointestinal (GI) motility and visceral hypersensitivity are considered to be important mechanisms involved in the pathophysiology of IBS [12]. However, none of these explain all the different symptoms in IBS and the relative importance of central versus peripheral factors for the various symptoms in IBS is much debated and not entirely known. In an attempt to understand the interaction between central and peripheral pathophysiological factors, a more integrated model of brain–gut interactions proposes that the central and enteric nervous systems interact and modulate altered motility, abnormal sensation and autonomic reactivity: the brain–gut axis [13]. Recent studies have provided evidence that IBS is due to a dysregulation of the brain–gut axis, with peripheral alterations probably dominating in some patients and disturbed central processing of signals from the periphery dominating in others. Still, factors in the periphery, such as visceral hypersensitivity, and abnormal GI motility and secretion are considered to be key factors in the pathophysiology, contributing to the main symptoms of IBS, i.e. abdominal pain/discomfort, bloating and abnormal bowel function resulting in diarrhoea and/or constipation. However, it should be stressed that this does not negate the importance of central mechanisms in IBS as well.

This article will review the literature on findings in IBS patients supporting involvement of peripheral factors in the pathophysiology of IBS. During recent years low-grade inflammation and alterations in the gut flora are other peripheral factors found to be of potential importance for IBS, but they will be reviewed elsewhere in this publication, and are therefore not discussed in detail in this review.

Section snippets

Esophageal and gastric motility

The hallmark symptoms of IBS are likely to have their origin in the large and small bowel, but upper GI symptoms are also frequently reported by IBS patients [14]. Therefore, even though most studies of motility in IBS have focused on the large and small bowel, there are also reports on disturbed motility in the oesophagus and the stomach. Patients with IBS demonstrate, for instance, lower pressure in the lower oesophageal sphincter and more oesophageal contraction abnormalities than healthy

Disturbed gas handling

Bloating and/or abdominal distension are reported by the vast majority of IBS patients [96]. Even though the underlying mechanisms behind these troublesome symptoms are not entirely known, studies during the last years support the fact that several pathophysiological factors are probably involved. It has also been concluded that mechanisms behind the sensation of abdominal swelling (bloating) versus an actual increase in girth (distension) may differ. By using a washout technique with

GI secretion in IBS

Few studies have so far addressed GI secretion in IBS, partly due to methodological problems in assessing secretion. An old study demonstrated that patients with IBS have enhanced intestinal secretion in response to perfused bile acids in the ileum, relative to controls [113]. By simultaneously assessing small intestinal motility (manometry) and chloride secretion (transmucosal potential difference) [114], [115], [116], our group has found an enhanced reactivity of the secretory component of

Visceral hypersensitivity

Since James Ritchie in 1973 demonstrated colonic hyperalgesia by inflating balloons in the sigmoid colon in patients with “the irritable colon syndrome” [118] numerous reports on visceral hypersensitivity in IBS have appeared [100], [119], [120], and rectal hypersensitivity has been proposed to be a biological marker for IBS [119], and useful to discriminate IBS from other GI diseases [121]. However, this has been questioned [122], and importantly visceral hypersensitivity is not present in all

Conclusion

There is strong evidence supporting involvement of altered gastrointestinal motility and secretion, as well as visceral hypersensitivity, in the generation of the hallmark symptoms of IBS. To what extent these alterations depend on alterations in the periphery and/or in the central nervous system, remains unclear, but it seems likely that normalization of these pathophysiological factors could improve symptoms in IBS.

Conflict of interest statement

None declared.

List of abbreviations

EGG, electrogastrography; GI, gastrointestinal; HAPC, high-amplitude propagating contraction; IBS, irritable bowel syndrome; MMC, migrating motor complex; SIBO, small intestinal bacterial overgrowth.

References (143)

  • A. Leahy et al.

    Abnormalities of the electrogastrogram in functional gastrointestinal disorders

    Am J Gastroenterol

    (1999)
  • P. Kerlin et al.

    Variability of motility of the ileum and jejunum in healthy humans

    Gastroenterology

    (1982)
  • J.E. Kellow et al.

    Human interdigestive motility: variations in patterns from esophagus to colon

    Gastroenterology

    (1986)
  • D.G. Thompson et al.

    Abnormal small-bowel motility demonstrated by radiotelemetry in a patient with irritable colon

    Lancet

    (1979)
  • J.E. Kellow et al.

    Altered small bowel motility in irritable bowel syndrome is correlated with symptoms

    Gastroenterology

    (1987)
  • J.E. Kellow et al.

    Prolonged ambulant recordings of small bowel motility demonstrate abnormalities in the irritable bowel syndrome

    Gastroenterology

    (1990)
  • J.E. Kellow et al.

    Enhanced perception of physiological intestinal motility in the irritable bowel syndrome

    Gastroenterology

    (1991)
  • P.R. Evans et al.

    Jejunal sensorimotor dysfunction in irritable bowel syndrome: clinical and psychosocial features

    Gastroenterology

    (1996)
  • M. Pimentel et al.

    Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome

    Am J Gastroenterol

    (2000)
  • M. Pimentel et al.

    Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study

    Am J Gastroenterol

    (2003)
  • W.J. Snape et al.

    Colonic myoelectric activity in the irritable bowel syndrome

    Gastroenterology

    (1976)
  • W.J. Snape et al.

    Evidence that abnormal myoelectrical activity produces colonic motor dysfunction in the irritable bowel syndrome

    Gastroenterology

    (1977)
  • P. Latimer et al.

    Colonic motor and myoelectrical activity: a comparative study of normal subjects, psychoneurotic patients, and patients with irritable bowel syndrome

    Gastroenterology

    (1981)
  • W.Y. Chey et al.

    Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea

    Am J Gastroenterol

    (2001)
  • M.J. Vassallo et al.

    Colonic tone and motility in patients with irritable bowel syndrome

    Mayo Clin Proc

    (1992)
  • M. Corsetti et al.

    Rectal hyperreactivity to distention in patients with irritable bowel syndrome: role of distention rate

    Clin Gastroenterol Hepatol

    (2004)
  • C.H. Clemens et al.

    Association between pain episodes and high amplitude propagated pressure waves in patients with irritable bowel syndrome

    Am J Gastroenterol

    (2003)
  • W. Atkinson et al.

    Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome

    Gastroenterology

    (2006)
  • M. Simrén et al.

    Lipid-induced colonic hypersensitivity in the irritable bowel syndrome: the role of bowel habit, sex, and psychologic factors

    Clin Gastroenterol Hepatol

    (2007)
  • M. Vassallo et al.

    Transit through the proximal colon influences stool weight in the irritable bowel syndrome

    Gastroenterology

    (1992)
  • F. Charles et al.

    Scintigraphy of the whole gut: clinical evaluation of transit disorders

    Mayo Clin Proc

    (1995)
  • P. Welgan et al.

    Effect of anger on colon motor and myoelectric activity in irritable bowel syndrome

    Gastroenterology

    (1988)
  • L. Chang et al.

    Sensation of bloating and visible abdominal distension in patients with irritable bowel syndrome

    Am J Gastroenterol

    (2001)
  • L.A. Houghton et al.

    Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit

    Gastroenterology

    (2006)
  • A. Agrawal et al.

    Bloating and distention in irritable bowel syndrome: the role of visceral sensation

    Gastroenterology

    (2008)
  • I. Posserud et al.

    Altered rectal perception in irritable bowel syndrome is associated with symptom severity

    Gastroenterology

    (2007)
  • R. Spiller et al.

    Guidelines on the irritable bowel syndrome: mechanisms and practical management

    Gut

    (2007)
  • W.G. Thompson et al.

    Irritable bowel syndrome in general practice: prevalence, characteristics, and referral

    Gut

    (2000)
  • C.A. Thompson

    Alosetron withdrawn from market

    Am J Health Syst Pharm

    (2001)
  • G.F. Longstreth et al.

    Irritable bowel-type symptoms in HMO examinees. Prevalence, demographics, and clinical correlates

    Dig Dis Sci

    (1993)
  • F. Mearin et al.

    Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population

    Scand J Gastroenterol

    (2001)
  • M. Simrén et al.

    Quality of life and illness costs in irritable bowel syndrome

    Digestion

    (2004)
  • D.A. Drossman

    Review article: an integrated approach to the irritable bowel syndrome

    Aliment Pharmacol Ther

    (1999)
  • G.R. Locke et al.

    Overlap of gastrointestinal symptom complexes in a US community

    Neurogastroenterol Motil

    (2005)
  • P.J. Whorwell et al.

    Oesophageal motility in the irritable bowel syndrome

    Br Med J

    (1981)
  • R.E. Clouse et al.

    Gastrointestinal symptoms of patients with esophageal contraction abnormalities

    Dig Dis Sci

    (1986)
  • M. Corsetti et al.

    Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia

    Am J Gastroenterol

    (2004)
  • H.J. van Wijk et al.

    Gastric emptying and dyspeptic symptoms in the irritable bowel syndrome

    Scand J Gastroenterol

    (1992)
  • A.M. Caballero-Plasencia et al.

    Altered gastric emptying in patients with irritable bowel syndrome

    Eur J Nucl Med

    (1999)
  • P. Portincasa et al.

    Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome

    World J Gastroenterol

    (2003)
  • Cited by (50)

    View all citing articles on Scopus
    View full text